- Drug Pipelines
- November 2019
- 75 Pages
Global
From €1928EUR$2,000USD£1,649GBP
The Bone Fracture Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. These drugs are used to treat bone fractures, which are breaks in the continuity of the bone. Bone fractures can be caused by trauma, such as a fall or a car accident, or by medical conditions such as osteoporosis. Bone fracture drugs are used to reduce pain, promote healing, and reduce the risk of complications. They can be administered orally, topically, or intravenously. Commonly used bone fracture drugs include bisphosphonates, calcitonin, and teriparatide.
Some companies in the Bone Fracture Drug market include Amgen, Eli Lilly, Merck, Novartis, and Pfizer. Show Less Read more